BioMedTracker

Event Alerts

Date	Lead Company	Event	Type	Approval Change	Approval Likelihood
01/27/12	Amylin (AMLN)	Bydureon for Diabetes Mellitus, Type II	Subscribers Only	Subscribers Only	Subscribers Only
01/27/12	Pfizer (PFE)	Inlyta for Renal Cell Cancer (RCC)	Subscribers Only	Subscribers Only	Subscribers Only
01/27/12	Infinity Pharmaceuticals, Inc. (INFI)	Saridegib for Pancreatic Cancer	Subscribers Only	Subscribers Only	Subscribers Only
01/27/12	Pfizer (PFE)	Bosutinib for Chronic Myelogenous Leukemia (CML)	Subscribers Only	Subscribers Only	Subscribers Only
01/26/12	Avila Therapeutics	AVL-292 for Hematologic Cancer	Subscribers Only	Subscribers Only	Subscribers Only
More...

	Expected Date Range	Lead Company	Drug	Expected Catalyst
	Now - 01/30/12	Subscribers Only	Subscribers Only	Regulatory - IND Filing
	01/30/12	Subscribers Only	Subscribers Only	Regulatory - PDUFA/Approval Decision (US)
	01/30/12	Subscribers Only	Subscribers Only	Company - Earnings Announcement
	Now - 01/31/12	Subscribers Only	Subscribers Only	Trial Announcement - Initiation
	Now - 01/31/12	Subscribers Only	Subscribers Only	Regulatory - Individual Country Filing (Europe)
More...

01/04/12	Nature Reviews Drug Discovery - 2011 in reflection (subscription required)
01/03/12	Nature Reviews Drug Discovery - Market Watch: Upcoming Market Catalysts in Q1 2012
11/15/11	SF Chronicle/Bloomberg News - Corporate venture funds boost biotech startups
10/26/11	SF Business Times - Biotech's new normal: Innovation but no VC money, risk More...